• OPEN AN ACCOUNT
Indian Indices
Nifty
24,712.05 -255.70
(-1.02%)
Sensex
80,786.54 -849.37
( -1.04%)
Bank Nifty
54,450.45 -688.85
( -1.25%)
Nifty IT
36,063.20 -216.85
( -0.60%)
Global Indices
Nasdaq
45,305.71 -347.04
(-0.76%)
Dow Jones
6,460.93 -26.98
(-0.42%)
Hang Seng
42,449.84 -357.98
(-0.84%)
Nikkei 225
9,321.40 12.20
(0.13%)
Forex
USD-INR
87.34 0.17
(0.20%)
EUR-INR
102.37 0.98
(0.96%)
GBP-INR
118.09 0.93
(0.80%)
JPY-INR
0.59 0.00
(0.82%)

EQUITY - MARKET SCREENER

Medicamen Organics Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
92885
INE0PE401018
24.7606838
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MEDIORG
14.64
47.97
EPS(TTM)
Face Value()
Div & Yield %
2.8
10
0
 

Naperol Investments reports standalone net profit of Rs 9.81 crore in the March 2025 quarter
May 07,2025
Net profit of Naperol Investments reported to Rs 9.81 crore in the quarter ended March 2025 as against net loss of Rs 0.55 crore during the previous quarter ended March 2024. Sales rose 5475.86% to Rs 16.17 crore in the quarter ended March 2025 as against Rs 0.29 crore during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 10.55 crore in the year ended March 2025 as against net loss of Rs 0.37 crore during the previous year ended March 2024. Sales rose 924.61% to Rs 19.57 crore in the year ended March 2025 as against Rs 1.91 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales16.170.29 5476 19.571.91 925
OPM %65.24-248.28 -56.97-32.98 -
PBDT10.66-0.72 LP 11.72-0.62 LP
PBT10.66-0.72 LP 11.72-0.62 LP
NP9.81-0.55 LP 10.55-0.37 LP